Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2169716 Target Snapshot

N-lysine methyltransferase SMYD2 · SINGLE PROTEIN · Homo sapiens

222Compounds
147Assays
0Approved Drugs
273.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9NRG4. Use UniProt Q9NRG4 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9NRG4 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats N-lysine methyltransferase SMYD2 as ChEMBL target CHEMBL2169716, mapped to UniProt Q9NRG4. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
N-lysine methyltransferase SMYD2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2169716
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9NRG4
N-lysine methyltransferase SMYD2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether N-lysine methyltransferase SMYD2 is the right protein anchor across sources, using UniProt Q9NRG4 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelN-lysine methyltransferase SMYD2
UniProt AccessionQ9NRG4
Component TypeProtein
Sequence Length433 aa

N-lysine methyltransferase SMYD2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as N-lysine methyltransferase SMYD2, mapped to UniProt Q9NRG4. Sequence length is 433 aa.

Mapped IDQ9NRG4
Review nameN-lysine methyltransferase SMYD2
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC50243.0
KI4.0
EC5021.0
KD5.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5746366 8.58 IC50 2.64 Preclinical
CHEMBL3590526 8.55 IC50 2.8 Preclinical
CHEMBL5187983 8.54 IC50 2.9 Preclinical
CHEMBL3819011 8.52 IC50 3.0 Preclinical
CHEMBL3590527 8.25 IC50 5.6 Preclinical
CHEMBL4536230 8.22 IC50 6.0 Preclinical
CHEMBL3818617 8.1 Ki 8.0 Preclinical
CHEMBL4520134 8.1 IC50 8.0 Preclinical
CHEMBL4756148 7.92 IC50 12.0 Preclinical
CHEMBL5789916 7.88 IC50 13.2 Preclinical
Distribution

pChEMBL Value Distribution

34
5.0
41
5.5
31
6.0
24
6.5
32
7.0
28
7.5
6
8.0
5
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

147
Total Assays
169
Tested Compounds
1
Assay Types
Binding — 147 assays, 169 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 78 75 6.2
cell-based format 51 68 6.5
assay format 11 26 6.4
tissue-based format 7 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine